Department of Health Service & Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
J Affect Disord. 2023 Dec 1;342:16-32. doi: 10.1016/j.jad.2023.09.007. Epub 2023 Sep 9.
Depression is highly prevalent in low- and middle- income countries (LMIC) and associated with significant cognitive dysfunction across multiple domains. However, little is known about neurocognitive tests used in people with depression in LMIC. We aimed to investigate cognitive performance and cognitive tests in depression research in LMIC.
APA PsycInfo, Embase, Ovid MEDLINE, and Global Health were systematically searched for studies that implemented a cognitive performance test in a depressed, LMIC population. Tool quality was assessed using an adapted scale for quality of measures in cross-cultural settings. Data extracted included demographics, depression and cognitive performance measures, and cognitive performance comparisons between depression and control groups.
29 studies met eligibility criteria, involving a total of 19,100 participants from 11 LMIC. 93.1 % of studies were conducted in upper middle-income countries. 67 cognitive performance tools were implemented. Reliability was reported for 5.6 % of cognitive performance tests and validity was reported for 8.3 %. 36.1 % of tests used were culturally adapted. 75.9 % of included studies implemented at least one memory test. Cognitive deficits were observed in all depressed groups, especially in memory (Cohen's d = -1.60, 95 % CI -2.02 to -1.18).
Heterogeneity between studies; averaged results across memory subtypes; no assessment of depression severity and cognitive deficits associations; restrictive search terms.
Cognitive impairments in depression, especially in memory, are prevalent in LMIC. This research has drawn attention to the burden of cognitive dysfunction in depression in LMIC, and to the disparate research gap in LMIC. PROSPERO registration CRD42022315397.
在中低收入国家(LMIC),抑郁症的发病率很高,且与多种认知领域的显著认知功能障碍相关。然而,在 LMIC 中,人们对抑郁症患者使用的神经认知测试知之甚少。我们旨在调查 LMIC 中抑郁症研究中的认知表现和认知测试。
我们系统地在 APA PsycInfo、Embase、Ovid MEDLINE 和全球健康数据库中搜索了在抑郁症 LMIC 人群中实施认知表现测试的研究。使用适用于跨文化环境下的测量工具质量的改良量表评估工具质量。提取的数据包括人口统计学、抑郁和认知表现测量以及抑郁组和对照组之间的认知表现比较。
符合入选标准的研究共有 29 项,涉及来自 11 个 LMIC 的共 19100 名参与者。93.1%的研究在中上收入国家进行。共实施了 67 种认知表现工具。报告了 5.6%的认知表现测试的可靠性,报告了 8.3%的认知表现测试的有效性。36.1%的测试工具经过了文化适应性调整。75.9%的纳入研究实施了至少一项记忆测试。所有抑郁组均观察到认知缺陷,尤其是在记忆方面(Cohen's d=-1.60,95%CI-2.02 至-1.18)。
研究间存在异质性;记忆亚型的平均结果;未评估抑郁严重程度与认知缺陷的相关性;搜索条件受限。
抑郁症患者,尤其是记忆方面,存在认知障碍,在 LMIC 中更为普遍。这项研究引起了人们对 LMIC 中抑郁症患者认知功能障碍负担的关注,也引起了人们对 LMIC 中认知研究差距的关注。PROSPERO 注册号 CRD42022315397。